GlassScriptPhysician profile
Drew M Huffman
NPI 1083728901
$19,584.91
in general payments reported to CMS, 2019-2025
48 companies · $2,875 in 2025
The $2,875 reported for 2025 was more than what 76% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,357 · 2020: $1,276 · 2021: $937 · 2022: $2,572 · 2023: $2,415 · 2024: $2,154 · 2025: $2,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,556 · Consulting Fee: $710 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,556.46 |
| Consulting Fee | $710.00 |
| Education | $176.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,160.14 | 2019-2025 | |
| Amgen INC. | $2,227.81 | 2019-2025 | Enbrel, Otezla, Otezla |
| Ucb, INC. | $1,172.87 | 2019-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $1,146.86 | 2019-2025 | Tremfya, Simponi Aria |
| Janssen Scientific Affairs, LLC | $841.25 | 2024 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $804.06 | 2021-2025 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $784.82 | 2019-2025 | |
| Glaxosmithkline, LLC. | $663.33 | 2019-2025 | Benlysta, Nucala |
| Pfizer INC. | $595.08 | 2019-2025 | |
| Horizon Therapeutics Plc | $443.01 | 2019-2023 | Krystexxa |
| E.R. Squibb & Sons, L.L.C. | $411.87 | 2019-2025 | Orencia |
| Lilly USA, LLC | $396.61 | 2019-2024 | Taltz, Zepbound |
| Radius Health, INC. | $351.95 | 2019-2025 | Tymlos |
| Mallinckrodt Hospital Products INC. | $349.35 | 2020-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $253.86 | 2023-2025 | Purified Cortrophin Gel |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.